TABLE OF CONTENTS |
FRONT PAGE
| NEXT ARTICLE |
PREVIOUS ARTICLE |
UNC HOMEPAGE
A protein discovered by Carolina scientists appears to play a key role in
determining the shape of cells and allowing them to move.
The newly identified protein, called palladin, is being explored for its
influence on a number of biological processes, including the invasive spread of
cancer, wound healing, brain development and the implantation of the embryo in
the uterus.
"I think it may be critically involved in even more biological functions," said
Carol A. Otey, assistant professor of cell and molecular physiology at the
School of Medicine.
A report of the discovery, co-written by Mana M. Parast of the University of
Virginia, was published in the Aug. 7 issue of the Journal of Cell Biology.
Otey said the new protein was named after Palladio, the influential
16th-century architect. Palladin appears to be quite involved in the
architecture of cells, specifically via the actin cytoskeleton, a polymer
protein complex that provides much of the basis for cell shape.
Otey's findings show that palladin belongs to a small group of cytoskeletal
adhesion proteins that seem to provide molecular "glue" for maintaining
cellular shape and for the attachment of cells to one another via their plasma
membranes.
An exciting thing about palladin is its presence in different forms, different
molecular weights. Otey noted that a heavier form of palladin is more highly
present in metastatic cancer cells -- tumor cells that spread beyond their
point of origin. "It is also this form of palladin we see highly expressed in
the early placenta, which, of course, is an `invasive' organ," said Otey.
Still, exactly what the new protein does in normal cells and in cancer cells
remains to be clarified further." In this first paper, we describe the
discovery of this protein -- it's basically a birth announcement," Otey said.
"All of the subsequent studies will be built on this. In the pipeline we have
projects related to neuroscience, orthopedic research, developmental biology,
including embryo implantation, and we're studying palladin in cancer
metastasis.
"I think in the next couple of years we'll see results that are more specific
to public health concerns."
This research is supported by grants from the National Institutes of Health.
TABLE OF CONTENTS |
FRONT PAGE
| NEXT ARTICLE |
PREVIOUS ARTICLE |
UNC HOMEPAGE